CD96, a new immune checkpoint, correlates with immune profile and clinical outcome of glioma

CD96 is a promising candidate for immunotherapy. However, its role and importance in glioma remains unknown. We thus aimed to genetically and clinically characterize CD96 expression in gliomas. For this, we extracted RNA-seq data of 699 glioma samples from the TCGA dataset and validated these findin...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fangkun, Huang, Jing, He, Fengqiong, Ma, Xiaodong, Fan, Fan, Meng, Ming, Zhuo, Yang, Zhang, Liyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330044/
https://www.ncbi.nlm.nih.gov/pubmed/32612110
http://dx.doi.org/10.1038/s41598-020-66806-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330044/
https://www.ncbi.nlm.nih.gov/pubmed/32612110
http://dx.doi.org/10.1038/s41598-020-66806-z

Ejemplares similares